Jack A. Khattar - 03 Dec 2021 Form 4 Insider Report for scPharmaceuticals Inc. (SCPH)

Role: Director
Signature: /s/ John H. Tucker, Attorney in Fact
Issuer symbol: SCPH
Transactions as of: 03 Dec 2021
Net transactions value: +$19,569
Form type: 4
Filing time: 06 Dec 2021, 16:55:14 UTC
Previous filing: 07 Oct 2021
Next filing: 24 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SCPH	Common Stock	Purchase	$19,569	+5,000		$3.91	5,000	03 Dec 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.90 to $3.923, inclusive. The reporting person undertakes to provide to scPharmaceuticals Inc., any security holder of scPharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4

Content

The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.90 to $3.923, inclusive. The reporting person undertakes to provide to scPharmaceuticals Inc., any security holder of scPharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4